ZENTIVA S.A. (RO:SCD) — Market Cap & Net Worth
Market Cap & Net Worth: ZENTIVA S.A. (SCD)
ZENTIVA S.A. (RO:SCD) has a market capitalization of $723.41 Million (RON3.15 Billion) as of May 11, 2026. Listed on the RO stock exchange, this Romania-based company holds position #10785 globally and #12 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ZENTIVA S.A.'s stock price RON4.52 by its total outstanding shares 697017040 (697.02 Million). Analyse cash efficiency ratio of ZENTIVA S.A. to see how efficiently the company converts income to cash.
ZENTIVA S.A. Market Cap History: 2015 to 2026
ZENTIVA S.A.'s market capitalization history from 2015 to 2026. Data shows growth from $326.49 Million to $723.41 Million (9.19% CAGR).
ZENTIVA S.A. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ZENTIVA S.A.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.65x
ZENTIVA S.A.'s market cap is 0.65 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.89x
ZENTIVA S.A.'s market cap is 2.89 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $512.15 Million | $599.01 Million | $43.75 Million | 0.85x | 11.71x |
| 2020 | $464.13 Million | $557.96 Million | $65.64 Million | 0.83x | 7.07x |
| 2021 | $390.51 Million | $709.93 Million | $105.75 Million | 0.55x | 3.69x |
| 2022 | $310.49 Million | $759.63 Million | $99.47 Million | 0.41x | 3.12x |
| 2023 | $467.34 Million | $953.63 Million | $192.62 Million | 0.49x | 2.43x |
| 2024 | $723.41 Million | $1.11 Billion | $250.51 Million | 0.65x | 2.89x |
Competitor Companies of SCD by Market Capitalization
Companies near ZENTIVA S.A. in the global market cap rankings as of May 11, 2026.
Key companies related to ZENTIVA S.A. by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #498 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #538 globally with a market cap of $49.29 Billion USD ( CN¥336.81 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #571 globally with a market cap of $45.88 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #654 globally with a market cap of $40.57 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #498 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #538 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $49.29 Billion | CN¥52.80 |
| #571 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $42.25 |
| #654 | Haleon plc | NYSE:HLN | $40.57 Billion | $9.11 |
ZENTIVA S.A. Historical Marketcap From 2015 to 2026
Between 2015 and today, ZENTIVA S.A.'s market cap moved from $326.49 Million to $ 723.41 Million, with a yearly change of 9.19%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | RON723.41 Million | 0.00% |
| 2025 | RON723.41 Million | 0.00% |
| 2024 | RON723.41 Million | +54.79% |
| 2023 | RON467.34 Million | +50.52% |
| 2022 | RON310.49 Million | -20.49% |
| 2021 | RON390.51 Million | -15.86% |
| 2020 | RON464.13 Million | -9.38% |
| 2019 | RON512.15 Million | +46.59% |
| 2018 | RON349.38 Million | +7.59% |
| 2017 | RON324.73 Million | +4.05% |
| 2016 | RON312.09 Million | -4.41% |
| 2015 | RON326.49 Million | -- |
End of Day Market Cap According to Different Sources
On May 11th, 2026 the market cap of ZENTIVA S.A. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $723.41 Million USD |
| MoneyControl | $723.41 Million USD |
| MarketWatch | $723.41 Million USD |
| marketcap.company | $723.41 Million USD |
| Reuters | $723.41 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ZENTIVA S.A.
Zentiva S.A. engages in the production and marketing of preparations and medicines for human use in Romania and internationally. The company develops pharmaceutical products in various therapeutic areas, such as cardiovascular diseases, anti-inflammatory and pain-relieving medications, urologists, blood diseases, gastrointestinal and metabolic disorders, central nervous system, infections, respir… Read more